Literature DB >> 24282058

Conflicting results on the efficacy of enteral nutrition during infliximab maintenance therapy for Crohn's disease are correct.

Mitsuro Chiba1, Tsuyotoshi Tsuji, Masafumi Komatsu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24282058     DOI： 10.1007/s10620-013-2954-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

1.  Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial.

Authors:  S Takagi; K Utsunomiya; S Kuriyama; H Yokoyama; S Takahashi; M Iwabuchi; H Takahashi; S Takahashi; Y Kinouchi; N Hiwatashi; Y Funayama; I Sasaki; I Tsuji; T Shimosegawa
Journal:  Aliment Pharmacol Ther       Date:  2006-11-01       Impact factor: 8.171

2.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

Authors:  Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van De Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad A van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Journal:  Lancet       Date:  2008-02-23       Impact factor: 79.321

3.  Reply: To PMID 22926500.

Authors:  Fumihito Hirai
Journal:  Dig Dis Sci       Date:  2013-06       Impact factor: 3.199

4.  Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn's disease.

Authors:  Takayuki Yamamoto; Maki Nakahigashi; Satoru Umegae; Koichi Matsumoto
Journal:  J Gastroenterol       Date:  2009-10-02       Impact factor: 7.527

5.  Efficacy of enteral nutrition during infliximab maintenance therapy in patients with Crohn's disease.

Authors:  Takayuki Yamamoto; Manabu Shiraki
Journal:  Dig Dis Sci       Date:  2012-11-30       Impact factor: 3.199

Review 6.  Mucosal healing in inflammatory bowel diseases: a systematic review.

Authors:  Markus F Neurath; Simon P L Travis
Journal:  Gut       Date:  2012-07-27       Impact factor: 23.059

7.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

8.  Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.

Authors:  David T Rubin; Ozgecan Uluscu; Robert Sederman
Journal:  Inflamm Bowel Dis       Date:  2012-02-22       Impact factor: 5.325

9.  Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults.

Authors:  Fumihito Hirai; Hiroshi Ishihara; Shinichirou Yada; Motohiro Esaki; Tomohisa Ohwan; Ryoichi Nozaki; Shinya Ashizuka; Haruhiko Inatsu; Hidehisa Ohi; Kunihiko Aoyagi; Yohei Mizuta; Takayuki Matsumoto; Toshiyuki Matsui
Journal:  Dig Dis Sci       Date:  2012-08-29       Impact factor: 3.199
  9 in total
  1 in total

1.  High amount of dietary fiber not harmful but favorable for Crohn disease.

Authors:  Mitsuro Chiba; Tsuyotoshi Tsuji; Kunio Nakane; Masafumi Komatsu
Journal:  Perm J       Date:  2015
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.